FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis

FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis

Submitted by admin on September 29, 2022 - 10:05am
Source: 
Pharmaceutical Business Review
News Tags: 
Sanofi
Regeneron
Dupixent
prurigo nodularis
FDA
Headline: 
FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis
snippet: 

This approval makes Dupixent the first and only medicine available in the US for the treatment of prurigo nodularis, a chronic and debilitating skin disease.

Do Not Allow Advertisers to Use My Personal information